Skip to main content

State Street Corp

SEC CIK
0000093751
Latest filing
Sep 22, 2026

RNAC holding history

Cartesian Therapeutics, Inc. in every 13F filed by State Street Corp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RNAC overviewAll 13F holders of RNACFull Q2 2026 holdings

Shares (Q2 2026)
249,212
Value
$2.60M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RNAC by State Street Corp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026249,212$2.60M<0.1%+48,875+24.4%AddedHolders
Q1 2026200,337$1.23M<0.1%+1,370+0.7%AddedHolders
Q4 2025198,967$1.43M<0.1%+1,301+0.7%AddedHolders
Q3 2025197,666$2.02M<0.1%+3,397+1.7%AddedHolders
Q2 2025194,269$2.02M<0.1%−6,856−3.4%ReducedHolders
Q1 2025201,125$2.65M<0.1%+28,505+16.5%AddedHolders
Q4 2024172,620$3.09M<0.1%+15,125+9.6%AddedHolders
Q3 2024157,495$2.54M<0.1%+3,830+2.5%AddedHolders
Q2 2024153,665$4.15M<0.1%−1,933,175−92.6%ReducedHolders
Q1 20242,086,840$1.36M<0.1%−115,012−5.2%ReducedHolders
Q4 20232,201,852$1.52M<0.1%+168,588+8.3%AddedHolders
Q3 20232,033,264$2.16M<0.1%+68,053+3.5%AddedHolders
Q2 20231,965,211$2.20M<0.1%+1,543,513+366.0%AddedHolders
Q1 2023421,698$586.2K<0.1%00.0%UnchangedHolders
Q4 2022421,698$476.5K<0.1%−2,500−0.6%ReducedHolders
Q3 2022424,198$696.0K<0.1%+38,400+10.0%AddedHolders
Q2 2022385,798$505.0K<0.1%−1,405,187−78.5%ReducedHolders
Q1 20221,790,985$2.20M<0.1%+80,662+4.7%AddedHolders
Q4 20211,710,323$5.58M<0.1%−2,719,665−61.4%ReducedHolders
Q3 20214,429,988$18.4M<0.1%+3,017,394+213.6%AddedHolders
Q2 20211,412,594$5.91M<0.1%+211,834+17.6%AddedHolders
Q1 20211,200,760$5.43M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.